Gullestad L - Search Results

1

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure.

Dahl CP, Aukrust P, Nymo SH, Kjekshus J, Cleland JG, McMurray JJ, Wikstrand J, Gullestad L, Ueland T. Dahl CP, et al. Among authors: gullestad l. Int J Cardiol. 2013 Oct 9;168(4):4427-9. doi: 10.1016/j.ijcard.2013.05.008. Epub 2013 May 26. Int J Cardiol. 2013. PMID: 23714594 No abstract available.

2

[Sudden cardiac death. Significance of beta blockaders].

Gullestad L, Kjekshus J. Gullestad L, et al. Tidsskr Nor Laegeforen. 1992 Sep 20;112(22):2843-7. Tidsskr Nor Laegeforen. 1992. PMID: 1357774 Review. Norwegian.

3

[Myocardial disease in diabetes mellitus].

Gullestad L, Kjekshus J. Gullestad L, et al. Tidsskr Nor Laegeforen. 1992 Mar 20;112(8):1016-9. Tidsskr Nor Laegeforen. 1992. PMID: 1553723 Review. Norwegian.

4

Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.

Gullestad L, Birkeland K, Nordby G, Larsen S, Kjekshus J. Gullestad L, et al. Br J Clin Pharmacol. 1991 Aug;32(2):201-7. doi: 10.1111/j.1365-2125.1991.tb03882.x. Br J Clin Pharmacol. 1991. PMID: 1681847 Free PMC article. Clinical Trial.

5

Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise.

Gullestad L, Dolva LO, Kjeldsen SE, Eide I, Kjekshus J. Gullestad L, et al. Cardiovasc Drugs Ther. 1989 Mar;3(1):63-71. doi: 10.1007/BF01881530. Cardiovasc Drugs Ther. 1989. PMID: 2577280 Clinical Trial.

6

Interaction of naloxone and timolol on maximal exercise capacity and the subjective perception of fatigue.

Gullestad L, Dolva LO, Aase O, Kjekshus J. Gullestad L, et al. Int J Sports Med. 1989 Aug;10(4):259-63. doi: 10.1055/s-2007-1024912. Int J Sports Med. 1989. PMID: 2606592 Clinical Trial.

7

[Angiotensin-converting enzyme inhibitors in heart failure].

Gullestad L, Søyland E, Dolva LO, Kjekshus J. Gullestad L, et al. Tidsskr Nor Laegeforen. 1987 Sep 10;107(25):2112-6. Tidsskr Nor Laegeforen. 1987. PMID: 2823410 Clinical Trial. Norwegian. No abstract available.

8

Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise.

Gullestad L, Dolva LO, Søyland E, Kjekshus J. Gullestad L, et al. Clin Physiol. 1988 Oct;8(5):487-99. doi: 10.1111/j.1475-097x.1988.tb00214.x. Clin Physiol. 1988. PMID: 3191663 Clinical Trial.

9

[Reduced physical tolerance in patients with heart failure. Mechanisms and therapeutic effects].

Gullestad L, Simonsen S, Kjekshus J. Gullestad L, et al. Tidsskr Nor Laegeforen. 1995 Jan 10;115(1):38-42. Tidsskr Nor Laegeforen. 1995. PMID: 7846658 Review. Norwegian.

10

[Intermittent claudication and beta-blockaders. An unfortunate combination?].

Andreassen AK, Gullestad L, Bjørnerheim R, Forfang K, Kjekshus J. Andreassen AK, et al. Among authors: gullestad l. Tidsskr Nor Laegeforen. 1995 Feb 28;115(6):725-8. Tidsskr Nor Laegeforen. 1995. PMID: 7900137 Review. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

527 results

Search Page

Filters